A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer

Clinical trial NCT06116786 · RECRUITING

Trial details

NCT number: NCT06116786
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-small-Cell Lung

Start date: 2023-11-27
Primary completion: 2027-04-14
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.